AP Biosciences Inc (TPEX:6945)
Taiwan · Delayed Price · Currency is TWD 172.00
+1.50 (0.88%)
Mar 4, 2026, 9:49 AM CST
AP Biosciences Market Cap
AP Biosciences has a market cap or net worth of 14.59 billion as of March 3, 2026. Its market cap has increased by 239.95% in one year.
Market Cap
14.59B
Enterprise Value
13.38B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
172.00
Market Cap Chart
Since July 14, 2023, AP Biosciences's market cap has increased from 5.10B to 14.59B, an increase of 186.33%. That is a compound annual growth rate of 49.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 14.85B | -3.09% |
| Dec 31, 2025 | 15.32B | 262.77% |
| Dec 31, 2024 | 4.22B | 39.97% |
| Dec 29, 2023 | 3.02B | -40.79% |
| Jul 14, 2023 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Polaris Group | 24.62B |
| Sunmax Biotechnology | 21.57B |
| EirGenix | 18.52B |
| TaiMed Biologics | 14.04B |
| Ever Supreme Bio Technology | 13.14B |
| Tanvex BioPharma | 12.87B |
| Medigen Vaccine Biologics | 11.90B |
| TCM Biotech International | 11.87B |